,trastuzumab deruxtecan
daiichi sankyo,roche,astrazeneca
['trastuzumab', 'bcsm', 'destinybreast03', 'improve ', 'breast']
first oral #breastcancer abstract at #asco22: more safety data from #destinybreast03 trial presented by the great that will be very helpful to improve our management of patients receiving #trastuzumabderuxtecan #bcsm 
Associate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Prior @myESMO fellow. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.